Skip to main content
Log in

MicroCT and Histological Analysis of Clot Composition in Acute Ischemic Stroke

A Comparative Study of MT-Retrieved Clots and Clot Analogs

  • Original Article
  • Published:
Clinical Neuroradiology Aims and scope Submit manuscript

Abstract

Purpose

Assessing clot composition on prethrombectomy computed tomography (CT) imaging may help in stroke treatment planning. In this study we seek to use microCT imaging of fabricated blood clots to understand the relationship between CT radiographic signals and the biological makeup.

Methods

Clots (n = 10) retrieved by mechanical thrombectomy (MT) were collected, and 6 clot analogs of varying RBC composition were made. We performed paired microCT and histological image analysis of all 16 clots using a ScanCo microCT 100 (4.9 µm resolution) and standard H&E staining (imaged at 40×). From these data types, first order statistic (FOS) radiomics were computed from microCT, and percent composition of RBCs (%RBC) was computed from histology. Polynomial and linear regression (LR) were used to build statistical models based on retrieved thrombus microCT and %RBC that were evaluated for their ability to predict the %RBC of clot analogs from mean HU. Correlation analyses of microCT FOS with composition were completed for both retrieved clots and analogs.

Results

The LR model fits relating MT-retrieved clot %RBC with mean (R2 = 0.625, p = 0.006) and standard deviation (R2 = 0.564, p < 0.05) in HUs on microCT were significant. Similarly, LR models relating analog histological %RBC to analog protocol %RBC (R2 = 0.915, p = 0.003) and mean HUs on microCT (R2 = 0.872, p = 0.007) were also significant. When the LR model built using MT-retrieved clots was used to predict analog %RBC from mean HUs, significant correlation was observed between predictions and actual histological %RBC (R2 = 0.852, p = 0.009). For retrieved clots, significant correlations were observed for energy and total energy with %RBC and %FP (|R| > 0.7, q < 0.01). Analogs further demonstrated significant correlation between FOS energy, total energy, variance and %WBC (|R| > 0.9, q < 0.01).

Conclusion

MicroCT can be used to build models that predict AIS clot composition from routine CT parameters and help us to better understand radiomic signatures associated with clot composition and first pass outcomes. In future work, such observations can be used to better infer clot composition and inform thrombectomy prognostics from pretreatment CTs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Fiehler J, Gerloff C. Mechanical thrombectomy in stroke. Dtsch Arztebl Int. 2015;112(49):830.

    PubMed  PubMed Central  Google Scholar 

  2. Johnson S, McCarthy R, Gilvarry M, McHugh PE, McGarry JP. Investigating the mechanical behavior of clot analogues through experimental and computational analysis. Ann Biomed Eng. 2021;49:420–31.

    Article  PubMed  Google Scholar 

  3. Shin JW, Jeong HS, Kwon H‑J, Song KS, Kim J. High red blood cell composition in clots is associated with successful recanalization during intra-arterial thrombectomy. PLoS ONE. 2018;13(5):e197492.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Singh P, Kaur R, Kaur A. Clot composition and treatment approach to acute ischemic stroke: the road so far. Ann Indian Acad Neurol. 2013;16(4):494.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Xu R‑G, Ariëns RA. Insights into the composition of stroke thrombi: heterogeneity and distinct clot areas impact treatment. Haematologica. 2020;105(2):257.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Mousavi Janbeh Sarayi SM, et al. Vascular cross-section, rather than tortuosity, can classify first-pass outcome of mechanical thrombectomy for Ischemic stroke. Stroke Vasc Interv Neurol. 2023;3(2):e646.

    Google Scholar 

  7. Hernández-Fernández F, et al. Fibrin-platelet clots in acute ischemic stroke. Predictors and clinical significance in a mechanical thrombectomy series. Front Neurol. 2021;12:631343.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Maekawa K, et al. Erythrocyte-rich thrombus is associated with reduced number of maneuvers and procedure time in patients with acute ischemic stroke undergoing mechanical thrombectomy. Cerebrovasc Dis Extra. 2018;8(1):39–49.

    Article  PubMed  PubMed Central  Google Scholar 

  9. LaGrange DD, et al. Predictive value of clot imaging in acute ischemic stroke: a systematic review of artificial intelligence and conventional studies. Neurosci Informatics. 2022; https://doi.org/10.1016/j.neuri.2022.100114.

    Article  Google Scholar 

  10. Hanning U, et al. Imaging-based prediction of histological clot composition from admission CT imaging. J NeuroIntervent Surg. 2021;13(11):1053–7.

    Article  Google Scholar 

  11. Wang C, et al. A nomogram for predicting thrombus composition in stroke patients with large vessel occlusion: combination of thrombus density and perviousness with clinical features. Neuroradiology. 2023;65(2):371–80.

    Article  PubMed  Google Scholar 

  12. Santo BA, et al. Multimodal CT imaging of ischemic stroke thrombi identifies scale-invariant radiomic features that reflect clot biology. J NeuroIntervent Surg. 2023; https://doi.org/10.1136/jnis-2022-019967.

    Article  Google Scholar 

  13. Duffy S, et al. Novel methodology to replicate clot analogs with diverse composition in acute ischemic stroke. J NeuroIntervent Surg. 2017;9(5):486–91.

    Article  Google Scholar 

  14. Fitzgerald S, et al. Novel human acute ischemic stroke blood clot analogs for in vitro thrombectomy testing. AJNR Am J Neuroradiol. 2021;42(7):1250–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Johnson S, Duffy S, Gunning G, Gilvarry M, McGarry J, McHugh P. Review of mechanical testing and modelling of thrombus material for vascular implant and device design. Ann Biomed Eng. 2017;45:2494–508.

    Article  CAS  PubMed  Google Scholar 

  16. Mousavi SJ, et al. Realistic computer modelling of stent retriever thrombectomy: a hybrid finite-element analysis-smoothed particle hydrodynamics model. J R Soc Interface. 2021;18(185):20210583.

    Article  Google Scholar 

  17. Tutino VM, et al. Circulating neutrophil transcriptome may reveal intracranial aneurysm signature. PLoS ONE. 2018;13(1):e191407.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Shinohara RT, et al. Statistical normalization techniques for magnetic resonance imaging. Neuroimage Clin. 2014;6:9–19.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Lie W‑N. Automatic target segmentation by locally adaptive image thresholding. IEEE Trans Image Process. 1995;4(7):1036–41.

    Article  CAS  PubMed  Google Scholar 

  20. Aerts HJ, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014;5(1):1–9.

    Google Scholar 

  21. Thissen D, Steinberg L, Kuang D. Quick and easy implementation of the Benjamini-Hochberg procedure for controlling the false positive rate in multiple comparisons. J Educ Behav Stat. 2002;27(1):77–83.

    Article  Google Scholar 

  22. Nelson LS. The Anderson-Darling test for normality. J Qual Technol. 1998;30(3):298.

    Article  Google Scholar 

  23. Hedna VS, et al. Hemispheric differences in ischemic stroke: is left-hemisphere stroke more common? J Clin Neurol. 2013;9(2):97–102.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Dumitriu LaGrange D, et al. MicroCT can characterize clots retrieved with mechanical thrombectomy from acute ischemic stroke patients—a preliminary report. Front Neurol. 2022;13:824091.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Patel TR, et al. Histomic-based clot structure quantification for prediction of ischemic stroke etiology. Circulation. 2022;146(1):A15640–A15640.

    Google Scholar 

  26. Patel TR, Santo B, Monteiro A, Waqas M, Siddiqui AH, Tutino V. Data-driven ischemic stroke clot phenotyping from whole-slide histopathology images. 2021 IEEE Western New York Image and Signal Processing Workshop (WNYISPW). IEEE; 2021. pp. 1–5.

    Google Scholar 

  27. Patel TR, et al. Histologically interpretable clot radiomic features predict treatment outcomes of mechanical thrombectomy for ischemic stroke. Neuroradiology. 2023; https://doi.org/10.1007/s00234-022-03109-2.

    Article  PubMed  Google Scholar 

  28. Patel TR, et al. Biologically informed clot histomics are predictive of acute ischemic stroke etiology. Stroke Vasc Interv Neurol. 2023;3(2):e536.

    Google Scholar 

  29. Liu Y, et al. Quantification of clot spatial heterogeneity and its impact on thrombectomy. J NeuroIntervent Surg. 2021; https://doi.org/10.1136/neurintsurg-2021-018075.

    Article  Google Scholar 

  30. Patel T, et al. Increased perviousness on CT for acute ischemic stroke is associated with fibrin/platelet-rich clots. AJNR Am J Neuroradiol. 2021;42(1):57–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Benson JC, et al. Clot permeability and histopathology: is a clot’s perviousness on CT imaging correlated with its histologic composition? J NeuroIntervent Surg. 2020;12(1):38–42.

    Article  Google Scholar 

  32. Minnerup J, Kleinschnitz C. Visualization of clot composition in ischemic stroke: do we get what we see? Am Heart Assoc. 2011;42:1193–4.

    Google Scholar 

  33. Fitzgerald S, et al. Per-pass analysis of acute ischemic stroke clots: impact of stroke etiology on extracted clot area and histological composition. J NeuroIntervent Surg. 2021;13(12):1111–6.

    Article  Google Scholar 

  34. Henninger N, Bouley J, Bråtane BT, Bastan B, Shea M, Fisher M. Laser Doppler flowmetry predicts occlusion but not tPA-mediated reperfusion success after rat embolic stroke. Exp Neurol. 2009;215(2):290–7.

    Article  CAS  PubMed  Google Scholar 

  35. Henninger N, Sicard KM, Schmidt KF, Bardutzky J, Fisher M. Comparison of ischemic lesion evolution in embolic versus mechanical middle cerebral artery occlusion in Sprague Dawley rats using diffusion and perfusion imaging. Stroke. 2006;37(5):1283–7.

    Article  PubMed  Google Scholar 

  36. Tashiro K, Shobayashi Y, Hotta A. Numerical simulation of non-linear loading-unloading hysteresis behavior of blood clots. Biocybern Biomed Eng. 2022;42(4):1205–17.

    Article  Google Scholar 

Download references

Acknowledgements

The authors would like to acknowledge Jay Shah for assistance in clot fabrication. Histology data in this study was generated with the assistance of the Histology Core Laboratory at the University at Buffalo’s Jacobs School of Medicine and Biomedical Sciences. MicroCT data were acquired at the University of Buffalo’s Optical Imaging and Analysis Facility.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vincent M. Tutino.

Ethics declarations

Conflict of interest

B.A. Santo, T.D. Jenkins, S.-S.K. Ciecierska and A.A. Baig declare that they have no competing interests. E.I. Levy—Board Membership: Stryker, NeXtGen Biologics, MedX Health, Cognition Medical, EndoStream; Consultancy: Claret Medical, GLG Consulting, Guidepoint, Imperative Care, Medtronic, Rebound Therapeutics, StimMed; Employment: University at Buffalo Neurosurgery Inc; Expert Testimony: renders medical/legal opinions as an expert witness; Stock/Stock Options: NeXtGen Biologics, Cognition Medical, Rapid Medical, Claret Medical, Imperative Care, Rebound Therapeutics, StimMed. A.H. Siddiqui—Financial interest/investor/stock options/ownership: Adona Medical, Inc., Amnis Therapeutics, BlinkTBI, Inc., Boston Scientific Corp. (for purchase of Claret Medical), Buffalo Technology Partners, Inc., Cardinal Consultants, LLC, Cerebrotech Medical Systems, Inc., Cognition Medical, Endostream Medical, Ltd, Imperative Care, Inc., International Medical Distribution Partners, Neurovascular Diagnostics, Inc., Q’Apel Medical, Inc., Radical Catheter Technologies, Inc., Rebound Therapeutics Corp. (purchased 2019 by Integra Lifesciences, Corp.), Rist Neurovascular, Inc., Sense Diagnostics, Inc., Serenity Medical, Inc., Silk Road Medical, Spinnaker Medical, Inc., StimMed, Synchron, Three Rivers Medical, Inc., Vastrax, LLC, VICIS, Inc., Viseon, Inc.; consultant/advisory board: Amnis Therapeutics, Boston Scientific, Canon Medical Systems USA, Inc., Cerebrotech Medical Systems, Inc., Cerenovus, Corindus, Inc., Endostream Medical, Ltd, Imperative Care, Inc., Integra LifeSciences Corp., Medtronic, MicroVention, Minnetronix Neuro, Inc., Northwest University—DSMB Chair for HEAT Trial, Penumbra, Q’Apel Medical, Inc., Rapid Medical, Rebound Therapeutics Corp., Serenity Medical, Inc., Silk Road Medical, StimMed, Stryker, Three Rivers Medical, Inc., VasSol, W.L. Gore & Associates; national PI/steering committees: Cerenovus LARGE trial and ARISE II trial, Medtronic SWIFT PRIME and SWIFT DIRECT trials, MicroVention FRED Trial and CONFIDENCE study, MUSC POSITIVE trial, Penumbra 3D Separator trial, COMPASS trial, INVEST trial; research grants: co-investigator, NIH/NINDS 1R01NS091075 Virtual Intervention of Intracranial Aneurysms; role: co-principal investigator, NIH-NINDS R21 NS109575-01 Optimizing Approaches to Endovascular Therapy of Acute Ischemic Stroke. V.M. Tutino—Financial interest/investor/stock options/ownership: Neurovascular Diagnostics, Inc., QAS.AI, Inc.; Consultant/advisory board: Canon Medical Systems USA; Research grants: Principal investigator, National Science Foundation Award No. 1746694 and NIH NINDS award R43 NS115314‑0; awardee of a Brain Aneurysm Foundation grant, a Center for Advanced Technology grant, and a Cummings Foundation grant.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The authors Briana A. Santo and TaJania D. Jenkins contributed equally to the manuscript.

Supplementary Information

62_2023_1380_MOESM1_ESM.pdf

Supplemental Table 1: Percent Compositions of All Retrieved Clots. Supplemental Table 2: Summary of radiomic feature and histological composition correlations for retrieved clots and synthetic clot analogs.  Supplemental Figure 1: Iodine-stained and unstained thrombi were qualitatively and quantitatively comparable by histology. Supplemental Figure 2: Summary of thrombectomy outcome and clot image data for the patient cohort. Supplemental Figure 3: Clot analog histological compositions reflected RBC proportions used in the experimental protocol

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Santo, B.A., Jenkins, T.D., Ciecierska, SS.K. et al. MicroCT and Histological Analysis of Clot Composition in Acute Ischemic Stroke. Clin Neuroradiol (2024). https://doi.org/10.1007/s00062-023-01380-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00062-023-01380-1

Keywords

Navigation